Table 1.
Diagnosis | Gender | Dysarthria | Dysphagia | Tongue weak | Bright tongue | Tongue atrophy | EMG tongue | |
---|---|---|---|---|---|---|---|---|
p1 | Pompe | M | No | No | No | Yes | No | No |
p2 | Pompe | M | No | No | No | Yes | Yes | No |
p3 | Pompe | F | No | Yes | Yes | Yes | No | No |
p4 | Pompe | F | No | No | No | No | No | No |
p5 | Pompe | M | No | No | No | No | No | No |
p6 | Pompe | M | No | No | No | No | No | No |
p8 | ALS (B) | M | Yes | Yes | Yes | Yes | Yes, mild | Yes, abnormal |
p9 | ALS (B) | F | Yes | Yes | Yes | No | No | No |
p10 | ALS (B) | F | Yes | Yes | Yes | No | No | Yes, abnormal |
p11 | ALS (B) | M | No | Yes | Yes | No | Yes, mild | Yes, abnormal |
p12 | ALS (B) | F | Yes | Yes | Yes | No | No | No |
p13 | ALS (B) | F | Yes | Yes | Yes | No | No | No |
p14 | ALS (B) | F | No | Yes | Yes | No | Yes | No |
p15 | ALS (B) | F | Yes | Yes | Yes | Yes | Yes | Yes, abnormal |
p16 | ALS (L) | M | Yes | Yes | Yes | No | No | Yes, normal |
p17 | ALS (L) | M | Yes | Yes | Yes | No | No | No |
p18 | ALS (L) | F | Yes | Yes | Yes | Yes | No | No |
p19 | ALS (L) | F | No | No | No | No | No | Yes, normal |
p20 | ALS (L) | F | No | Yes | No | No | No | No |
p21 | ALS (L) | M | No | No | No | No | No | No |
p22 | ALS (L) | M | No | No | No | No | No | No |
p23 | ALS (B) | F | Yes | Yes | Yes | Artifact | Artifact | Yes, abnormal |
p24 | ALS (L) | F | No | No | No | No | No | Yes, normal |
p25 | PLS (L) | M | Yes | Yes | No | No | No | Yes, normal |
p26 | PLS (L) | F | Yes | Yes | No | No | No | Yes, normal |
p27 | PLS (B) | F | Yes | Yes | No | No | No | Yes, normal |
p28 | FSHD | F | No | Yes | No | No | No | No |
p29 | IBM | F | No | Yes | No | No | No | No |
p30 | IBM | M | No | Yes | No | No | No | No |
p31 | IBM | F | No | No | No | No | No | No |
p32 | IBM | M | No | No | No | No | No | No |
p33 | MD1 | M | No | No | No | No | No | No |
p34 | MD1 | F | No | Yes | Yes | NS | NS | No |
p35 | MD1 | F | No | No | No | Yes | Yes | No |
p36 | MD1 | M | No | No | No | No | No | No |
P patient, M male, F female, ALS amyotrophic lateral sclerosis, PLS progressive lateral sclerosis, IBM inclusion body myositis, MD1 myotonic dystrophy type 1